JP7645654B2 - Oil-in-water emulsion cosmetics - Google Patents
Oil-in-water emulsion cosmetics Download PDFInfo
- Publication number
- JP7645654B2 JP7645654B2 JP2021019991A JP2021019991A JP7645654B2 JP 7645654 B2 JP7645654 B2 JP 7645654B2 JP 2021019991 A JP2021019991 A JP 2021019991A JP 2021019991 A JP2021019991 A JP 2021019991A JP 7645654 B2 JP7645654 B2 JP 7645654B2
- Authority
- JP
- Japan
- Prior art keywords
- mass
- oil
- cosmetic
- content
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002537 cosmetic Substances 0.000 title claims description 95
- 239000007764 o/w emulsion Substances 0.000 title claims description 13
- 239000002245 particle Substances 0.000 claims description 70
- 125000000217 alkyl group Chemical group 0.000 claims description 33
- 229910044991 metal oxide Inorganic materials 0.000 claims description 32
- 150000004706 metal oxides Chemical class 0.000 claims description 32
- 229920013820 alkyl cellulose Polymers 0.000 claims description 25
- 238000002360 preparation method Methods 0.000 claims description 21
- 239000002562 thickening agent Substances 0.000 claims description 21
- 239000008346 aqueous phase Substances 0.000 claims description 19
- 239000002736 nonionic surfactant Substances 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 17
- 239000002253 acid Substances 0.000 claims description 16
- 229920001296 polysiloxane Polymers 0.000 claims description 11
- 239000002563 ionic surfactant Substances 0.000 claims description 9
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical class OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 7
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 6
- 230000004224 protection Effects 0.000 claims description 6
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims description 6
- 230000005661 hydrophobic surface Effects 0.000 claims description 4
- 229920000058 polyacrylate Polymers 0.000 claims description 3
- 229920002554 vinyl polymer Polymers 0.000 claims description 3
- 239000003921 oil Substances 0.000 description 41
- 235000019198 oils Nutrition 0.000 description 41
- -1 silane compound Chemical class 0.000 description 23
- 239000000839 emulsion Substances 0.000 description 17
- 238000011282 treatment Methods 0.000 description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 239000004094 surface-active agent Substances 0.000 description 11
- 125000004432 carbon atom Chemical group C* 0.000 description 10
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 8
- 239000001993 wax Substances 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- 229940008099 dimethicone Drugs 0.000 description 7
- 239000004205 dimethyl polysiloxane Substances 0.000 description 7
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 7
- 230000001804 emulsifying effect Effects 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 7
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- HEAHZSUCFKFERC-IWGRKNQJSA-N [(2e)-2-[[4-[(e)-[7,7-dimethyl-3-oxo-4-(sulfomethyl)-2-bicyclo[2.2.1]heptanylidene]methyl]phenyl]methylidene]-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl]methanesulfonic acid Chemical group CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)\C2=C\C(C=C1)=CC=C1\C=C/1C(=O)C2(CS(O)(=O)=O)CCC\1C2(C)C HEAHZSUCFKFERC-IWGRKNQJSA-N 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000002209 hydrophobic effect Effects 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 238000002834 transmittance Methods 0.000 description 5
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 238000010306 acid treatment Methods 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 239000002826 coolant Substances 0.000 description 4
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 4
- 239000004926 polymethyl methacrylate Substances 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical class CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 3
- KXTAOXNYQGASTA-UHFFFAOYSA-N 2-benzylidenepropanedioic acid Chemical class OC(=O)C(C(O)=O)=CC1=CC=CC=C1 KXTAOXNYQGASTA-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000006096 absorbing agent Substances 0.000 description 3
- 229920003086 cellulose ether Polymers 0.000 description 3
- 239000013068 control sample Substances 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 239000002270 dispersing agent Substances 0.000 description 3
- 239000010696 ester oil Substances 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 230000015784 hyperosmotic salinity response Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 3
- 230000008719 thickening Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 2
- NIELXDCPHZJHGM-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NIELXDCPHZJHGM-UHFFFAOYSA-N 0.000 description 2
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 2
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 2
- DWYHDSLIWMUSOO-UHFFFAOYSA-N 2-phenyl-1h-benzimidazole Chemical class C1=CC=CC=C1C1=NC2=CC=CC=C2N1 DWYHDSLIWMUSOO-UHFFFAOYSA-N 0.000 description 2
- BVNWQSXXRMNYKH-UHFFFAOYSA-N 4-phenyl-2h-benzotriazole Chemical class C1=CC=CC=C1C1=CC=CC2=C1NN=N2 BVNWQSXXRMNYKH-UHFFFAOYSA-N 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 2
- 150000008316 benzisoxazoles Chemical class 0.000 description 2
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 2
- 150000008366 benzophenones Chemical class 0.000 description 2
- 229940094978 bis-peg-18 methyl ether dimethyl silane Drugs 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 2
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical class C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- WODOUQLMOIMKAL-FJSYBICCSA-L disodium;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O WODOUQLMOIMKAL-FJSYBICCSA-L 0.000 description 2
- GLCJMPWWQKKJQZ-UHFFFAOYSA-L disodium;2-[4-(4,6-disulfonato-1h-benzimidazol-2-yl)phenyl]-1h-benzimidazole-4,6-disulfonate;hydron Chemical compound [Na+].[Na+].C1=C(S(O)(=O)=O)C=C2NC(C3=CC=C(C=C3)C3=NC4=C(C=C(C=C4N3)S(=O)(=O)O)S([O-])(=O)=O)=NC2=C1S([O-])(=O)=O GLCJMPWWQKKJQZ-UHFFFAOYSA-L 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- HUVYTMDMDZRHBN-UHFFFAOYSA-N drometrizole trisiloxane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)CC(C)CC1=CC(C)=CC(N2N=C3C=CC=CC3=N2)=C1O HUVYTMDMDZRHBN-UHFFFAOYSA-N 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 2
- 229960000655 ensulizole Drugs 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 150000002462 imidazolines Chemical class 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- ZYTMANIQRDEHIO-KXUCPTDWSA-N isopulegol Chemical compound C[C@@H]1CC[C@@H](C(C)=C)[C@H](O)C1 ZYTMANIQRDEHIO-KXUCPTDWSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 2
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 2
- 229960001173 oxybenzone Drugs 0.000 description 2
- 229940083254 peripheral vasodilators imidazoline derivative Drugs 0.000 description 2
- 229920002282 polysilicones-15 Polymers 0.000 description 2
- 239000011164 primary particle Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 2
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 2
- 229910000077 silane Inorganic materials 0.000 description 2
- 229920002050 silicone resin Polymers 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- 150000003918 triazines Chemical class 0.000 description 2
- UEVAMYPIMMOEFW-UHFFFAOYSA-N trolamine salicylate Chemical compound OCCN(CCO)CCO.OC(=O)C1=CC=CC=C1O UEVAMYPIMMOEFW-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- 239000001871 (1R,2R,5S)-5-methyl-2-prop-1-en-2-ylcyclohexan-1-ol Substances 0.000 description 1
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- VUHMIPWBDMGTNL-MHCZMQLOSA-N 1,2-dimethoxy-4-[(e)-prop-1-enyl]benzene;1,2,4-trimethoxy-5-[(e)-prop-1-enyl]benzene Chemical compound COC1=CC=C(\C=C\C)C=C1OC.COC1=CC(OC)=C(\C=C\C)C=C1OC VUHMIPWBDMGTNL-MHCZMQLOSA-N 0.000 description 1
- QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical compound O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- NWGAAWUUGRXXSC-UHFFFAOYSA-N 1-(2-hydroxypropoxy)propan-2-yl 2-hydroxybenzoate Chemical compound CC(O)COCC(C)OC(=O)C1=CC=CC=C1O NWGAAWUUGRXXSC-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 1
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- WHQOKFZWSDOTQP-UHFFFAOYSA-N 2,3-dihydroxypropyl 4-aminobenzoate Chemical compound NC1=CC=C(C(=O)OCC(O)CO)C=C1 WHQOKFZWSDOTQP-UHFFFAOYSA-N 0.000 description 1
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- HSMMDRNFKHECNY-UHFFFAOYSA-N 2-(2,3-dihydroxypropyl)-2-ethylhexanoic acid;2,3-dimethoxy-3-phenylprop-2-enoic acid Chemical compound CCCCC(CC)(C(O)=O)CC(O)CO.COC(C(O)=O)=C(OC)C1=CC=CC=C1 HSMMDRNFKHECNY-UHFFFAOYSA-N 0.000 description 1
- ALBXRBNFWICCSC-UHFFFAOYSA-N 2-(5,5-dimethyl-1,1-diphenylhex-1-en-3-ylidene)propanedioic acid Chemical compound C=1C=CC=CC=1C(=CC(CC(C)(C)C)=C(C(O)=O)C(O)=O)C1=CC=CC=C1 ALBXRBNFWICCSC-UHFFFAOYSA-N 0.000 description 1
- 229920000536 2-Acrylamido-2-methylpropane sulfonic acid Polymers 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-Hydroxyoctadecanoic acid Natural products CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 1
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 1
- AYUKNFXLSTVUAB-UHFFFAOYSA-N 2-[2-[2-(2,2-dimethylpropanoyloxy)propoxy]propoxy]propyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OC(C)COC(C)COC(C)COC(=O)C(C)(C)C AYUKNFXLSTVUAB-UHFFFAOYSA-N 0.000 description 1
- MACVUTCNLULHLQ-UHFFFAOYSA-N 2-[methyl(octadecanoyl)amino]ethanesulfonic acid;sodium Chemical compound [Na].CCCCCCCCCCCCCCCCCC(=O)N(C)CCS(O)(=O)=O MACVUTCNLULHLQ-UHFFFAOYSA-N 0.000 description 1
- LSHGMOIQPURPAK-UHFFFAOYSA-N 2-benzylidene-1,4,7,7-tetramethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C(C2=O)(C)CCC1(C)C2=CC1=CC=CC=C1 LSHGMOIQPURPAK-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- JVXJFNLEXLGQIO-UHFFFAOYSA-N 2-hexyldecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC JVXJFNLEXLGQIO-UHFFFAOYSA-N 0.000 description 1
- OGJDIJKJFYOENF-UHFFFAOYSA-N 2-hexyldecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC OGJDIJKJFYOENF-UHFFFAOYSA-N 0.000 description 1
- ORWUQAQITKSSRZ-UHFFFAOYSA-N 2-hydroxyethyl 4-[bis[2-(2-hydroxyethoxy)ethyl]amino]benzoate Chemical compound OCCOCCN(CCOCCO)C1=CC=C(C(=O)OCCO)C=C1 ORWUQAQITKSSRZ-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- FRPAVHFNOFSNDR-UHFFFAOYSA-N 3-(2,4-dioxo-1,3-thiazolidin-3-yl)propanoic acid Chemical compound OC(=O)CCN1C(=O)CSC1=O FRPAVHFNOFSNDR-UHFFFAOYSA-N 0.000 description 1
- MDVYIGJINBYKOM-UHFFFAOYSA-N 3-[[5-Methyl-2-(1-methylethyl)cyclohexyl]oxy]-1,2-propanediol Chemical compound CC(C)C1CCC(C)CC1OCC(O)CO MDVYIGJINBYKOM-UHFFFAOYSA-N 0.000 description 1
- WHNPOQXWAMXPTA-UHFFFAOYSA-N 3-methylbut-2-enamide Chemical compound CC(C)=CC(N)=O WHNPOQXWAMXPTA-UHFFFAOYSA-N 0.000 description 1
- ZQXRINMCMHCYBD-UHFFFAOYSA-N 4-(2-ethylhexoxy)-4-oxobutanoic acid Chemical compound CCCCC(CC)COC(=O)CCC(O)=O ZQXRINMCMHCYBD-UHFFFAOYSA-N 0.000 description 1
- KKJKXQYVUVWWJP-JLHYYAGUSA-N 4-[(e)-(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanylidene)methyl]benzenesulfonic acid Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C\C1=CC=C(S(O)(=O)=O)C=C1 KKJKXQYVUVWWJP-JLHYYAGUSA-N 0.000 description 1
- CWMKYMMWCJOQFO-UHFFFAOYSA-N 4-[1-[2-[[2-[1-(2H-benzotriazol-4-yl)butyl]-6-methoxy-3,4,5-trimethylphenyl]methyl]-3-methoxy-4,5,6-trimethylphenyl]butyl]-2H-benzotriazole Chemical compound C(C1=C(C(=C(C(=C1C(CCC)C1=CC=CC=2NN=NC=21)C)C)C)OC)C1=C(C(=C(C(=C1C(CCC)C1=CC=CC=2NN=NC=21)C)C)C)OC CWMKYMMWCJOQFO-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- MVJSIAIXMFGVSA-UHFFFAOYSA-N 6-(2-hexyldecoxy)-6-oxohexanoic acid Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCC(O)=O MVJSIAIXMFGVSA-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- BIQUJLSTLXZGTO-UHFFFAOYSA-N C(CC)(=O)O.C(C)C=1C(=C(C(=C2N(C(C(N2)=O)=O)CCCCCC)OC)C=CC1)OC Chemical compound C(CC)(=O)O.C(C)C=1C(=C(C(=C2N(C(C(N2)=O)=O)CCCCCC)OC)C=CC1)OC BIQUJLSTLXZGTO-UHFFFAOYSA-N 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 239000006087 Silane Coupling Agent Substances 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 229920004482 WACKER® Polymers 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- OOHTWBUKWQKKEE-UHFFFAOYSA-N [6-(diethylamino)-6-hydroxy-7-oxo-7-phenylheptyl] benzoate Chemical compound C=1C=CC=CC=1C(=O)C(O)(N(CC)CC)CCCCCOC(=O)C1=CC=CC=C1 OOHTWBUKWQKKEE-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 229960002709 amiloxate Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940067599 ascorbyl glucoside Drugs 0.000 description 1
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 1
- 229960004101 bemotrizinol Drugs 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- 229940111759 benzophenone-2 Drugs 0.000 description 1
- 229940079894 benzophenone-9 Drugs 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- YEAYGXLRPMKZBP-KQGICBIGSA-N bis(2-hydroxyethyl)azanium;(e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound OCCNCCO.COC1=CC=C(\C=C\C(O)=O)C=C1 YEAYGXLRPMKZBP-KQGICBIGSA-N 0.000 description 1
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 1
- SHZIWNPUGXLXDT-UHFFFAOYSA-N caproic acid ethyl ester Natural products CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229920003174 cellulose-based polymer Polymers 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- QDCHWIWENYCPIL-UHFFFAOYSA-L disodium;4-hydroxy-5-(2-hydroxy-4-methoxy-5-sulfonatobenzoyl)-2-methoxybenzenesulfonate Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC(S([O-])(=O)=O)=C(OC)C=C1O QDCHWIWENYCPIL-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229960003747 ecamsule Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960004697 enzacamene Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- CBZHHQOZZQEZNJ-UHFFFAOYSA-N ethyl 4-[bis(2-hydroxypropyl)amino]benzoate Chemical compound CCOC(=O)C1=CC=C(N(CC(C)O)CC(C)O)C=C1 CBZHHQOZZQEZNJ-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229940068171 ethyl hexyl salicylate Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- GQXQIRNPJBUEGY-UHFFFAOYSA-N hexadecan-7-yl 2,2-dimethyloctanoate Chemical compound CCCCCCCCCC(CCCCCC)OC(=O)C(C)(C)CCCCCC GQXQIRNPJBUEGY-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940095045 isopulegol Drugs 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- SOXAGEOHPCXXIO-DVOMOZLQSA-N menthyl anthranilate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1N SOXAGEOHPCXXIO-DVOMOZLQSA-N 0.000 description 1
- SOXAGEOHPCXXIO-UHFFFAOYSA-N meradimate Chemical compound CC(C)C1CCC(C)CC1OC(=O)C1=CC=CC=C1N SOXAGEOHPCXXIO-UHFFFAOYSA-N 0.000 description 1
- 229960002248 meradimate Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- PVWXTVUZGJXFJQ-CCEZHUSRSA-N methyl (E)-4-methyl-3-phenyl-2-propan-2-ylpent-2-enoate Chemical compound COC(=O)C(\C(C)C)=C(/C(C)C)C1=CC=CC=C1 PVWXTVUZGJXFJQ-CCEZHUSRSA-N 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- UTTVXKGNTWZECK-UHFFFAOYSA-N n,n-dimethyloctadecan-1-amine oxide Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)[O-] UTTVXKGNTWZECK-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 description 1
- ZYTMANIQRDEHIO-UHFFFAOYSA-N neo-Isopulegol Natural products CC1CCC(C(C)=C)C(O)C1 ZYTMANIQRDEHIO-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- 229940088608 peg-9 polydimethylsiloxyethyl dimethicone Drugs 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000120 polyethyl acrylate Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229940100498 polysilicone-15 Drugs 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- XATKDVHSLQMHSY-RMKNXTFCSA-N propan-2-yl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound COC1=CC=C(\C=C\C(=O)OC(C)C)C=C1 XATKDVHSLQMHSY-RMKNXTFCSA-N 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- FWFUWXVFYKCSQA-UHFFFAOYSA-M sodium;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C FWFUWXVFYKCSQA-UHFFFAOYSA-M 0.000 description 1
- KJCLYACXIWMFCC-UHFFFAOYSA-M sodium;5-benzoyl-4-hydroxy-2-methoxybenzenesulfonate Chemical compound [Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 KJCLYACXIWMFCC-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229920003179 starch-based polymer Polymers 0.000 description 1
- 239000004628 starch-based polymer Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 229960000368 sulisobenzone Drugs 0.000 description 1
- 239000012756 surface treatment agent Substances 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Description
本発明は、水中油型乳化化粧料、特に赤外線防御用水中油型乳化化粧料に関する。 The present invention relates to an oil-in-water emulsion cosmetic, in particular an oil-in-water emulsion cosmetic for infrared protection.
従来、太陽光に対する皮膚防御の観点から、紫外線防御化粧料が知られている。 Conventionally, UV protective cosmetics have been known from the perspective of protecting the skin against sunlight.
例えば、特許文献1では、紫外線吸収剤及び紫外線散乱剤を含み、高い紫外線防御能(SPF)を持ちながら、独特のみずみずしい使用感触を有する水中油型乳化化粧料として、(A)0.05~1質量%の疎水変性アルキルセルロース;(B)5~40質量%の油分;(C)2.5~30質量%の疎水性表面を有する紫外線散乱剤;及び(D)耐塩性の低い水相増粘剤を含有し、(C)紫外線散乱剤が油相中に分散していることを特徴とする水中油型乳化化粧料が開示されている。 For example, Patent Document 1 discloses an oil-in-water emulsion cosmetic that contains an ultraviolet absorbing agent and an ultraviolet scattering agent, has high ultraviolet protection capability (SPF), and has a uniquely refreshing feel when used. The cosmetic contains (A) 0.05 to 1% by mass of hydrophobically modified alkyl cellulose; (B) 5 to 40% by mass of oil; (C) 2.5 to 30% by mass of an ultraviolet scattering agent having a hydrophobic surface; and (D) an aqueous phase thickener with low salt resistance, and the ultraviolet scattering agent (C) is dispersed in the oil phase.
一方で、近年では、健康意識が高まり、紫外線(波長:約290~約400nm)のみならず、赤外線(波長:約750nm~約1mm)もカットすることで太陽光の熱さを軽減し、皮膚の光老化を防げる化粧料が求められている。 On the other hand, in recent years, health consciousness has increased, and there is a demand for cosmetics that can reduce the heat of sunlight and prevent photoaging of the skin by blocking not only ultraviolet rays (wavelength: about 290 to about 400 nm) but also infrared rays (wavelength: about 750 nm to about 1 mm).
例えば、特許文献2では、紫外線遮断効果を持ちながら赤外線の遮熱効果を向上させた遮熱化粧料として、平均粒径5~100nmの酸化チタン(A)と平均粒径300~3000nmの酸化チタン(B)とが、(A):(B)=1:9~9:1(重量比)の割合で配合されていることを特徴とする、遮熱化粧料が開示されている。 For example, Patent Document 2 discloses a heat-shielding cosmetic that has an improved infrared heat-shielding effect while still retaining an ultraviolet ray blocking effect, and is characterized by the fact that titanium oxide (A) having an average particle size of 5 to 100 nm and titanium oxide (B) having an average particle size of 300 to 3000 nm are blended in a ratio of (A):(B) = 1:9 to 9:1 (weight ratio).
しかしながら、例えば特許文献2に開示されている遮熱化粧料は、ノニオン界面活性剤の配合量が多いため、みずみずしい使用感触を得ることが難しい問題がある。 However, for example, the heat-shielding cosmetic composition disclosed in Patent Document 2 contains a large amount of nonionic surfactant, which makes it difficult to achieve a fresh feel when used.
本発明は、上記の事情を改善しようとするものであり、その目的は、赤外線防御効果に優れて、かつ独特のみずみずしい使用感触を有する化粧料を提供することである。 The present invention aims to improve the above situation, and its purpose is to provide a cosmetic product that has excellent infrared protection effects and a unique, refreshing feel when used.
上記の目的を達成する本発明は、以下のとおりである。 The present invention, which achieves the above objective, is as follows:
〈態様1〉
下記成分(a)~(d)を含み:
(a)平均粒子径が500~1500nmであり、かつ表面疎水処理された金属酸化物粒子、
(b)疎水変性アルキルセルロース、
(c)水相増粘剤、及び
(d)油分、
前記金属酸化物粒子が、前記油分中に分散されており、かつ
HLB値が10以上のノニオン界面活性剤の含有量が、1.0質量%未満である、
水中油型乳化化粧料。
〈態様2〉
(e)ポリヒドロキシステアリン酸を更に含む、態様1に記載の化粧料。
〈態様3〉
前記金属酸化物粒子の含有量が、1.0質量%以上30.0質量%以下であり、
前記疎水変性アルキルセルロースの含有量が、0.05質量%以上1.0質量%以下であり、
前記水相増粘剤の含有量が、0.05質量%以上3.0質量%以下であり、かつ
前記油分の含有量が、5.0質量%以上40.0質量%以下である、
態様1又は2に記載の化粧料。
〈態様4〉
前記金属酸化物粒子が、酸化チタンである、態様1~3のいずれか一項に記載の化粧料。
〈態様5〉
前記疎水変性アルキルセルロースが、疎水変性ヒドロキシプロピルメチルセルロースである、態様1~4のいずれか一項に記載の化粧料。
〈態様6〉
前記水相増粘剤が、ビニル系高分子又はアクリル系高分子を含む、態様1~5のいずれか一項に記載の化粧料。
〈態様7〉
前記油分の55質量%以上が極性油である、態様1~6のいずれか一項に記載の化粧料。
〈態様8〉
(f)イオン界面活性剤を更に含む、態様1~7のいずれか一項に記載の化粧料。
〈態様9〉
(g)水溶性ポリエーテル変性シリコーンワックスを更に含む、態様1~8のいずれか一項に記載の化粧料。
〈態様10〉
赤外線防御用化粧料である、態様1~9のいずれか一項に記載の化粧料。
<Aspect 1>
Contains the following components (a) to (d):
(a) metal oxide particles having an average particle size of 500 to 1,500 nm and having a hydrophobic surface;
(b) hydrophobically modified alkyl cellulose;
(c) an aqueous phase thickener; and (d) an oil.
the metal oxide particles are dispersed in the oil, and the content of a nonionic surfactant having an HLB value of 10 or more is less than 1.0 mass%.
Oil-in-water emulsion cosmetic.
<Aspect 2>
The cosmetic preparation according to Aspect 1, further comprising (e) polyhydroxystearic acid.
Aspect 3
The content of the metal oxide particles is 1.0% by mass or more and 30.0% by mass or less,
The content of the hydrophobically modified alkyl cellulose is 0.05% by mass or more and 1.0% by mass or less,
The content of the aqueous phase thickener is 0.05% by mass or more and 3.0% by mass or less, and the content of the oil content is 5.0% by mass or more and 40.0% by mass or less.
A cosmetic preparation according to aspect 1 or 2.
<Aspect 4>
A cosmetic preparation according to any one of Aspects 1 to 3, wherein the metal oxide particles are titanium oxide.
<Aspect 5>
The cosmetic preparation according to any one of Aspects 1 to 4, wherein the hydrophobically modified alkyl cellulose is hydrophobically modified hydroxypropyl methyl cellulose.
<Aspect 6>
A cosmetic preparation according to any one of Aspects 1 to 5, wherein the aqueous phase thickener comprises a vinyl polymer or an acrylic polymer.
Aspect 7
A cosmetic preparation according to any one of Aspects 1 to 6, wherein 55% by mass or more of the oil component is a polar oil.
<Aspect 8>
The cosmetic preparation according to any one of Aspects 1 to 7, further comprising (f) an ionic surfactant.
<Aspect 9>
(g) The cosmetic preparation according to any one of Aspects 1 to 8, further comprising a water-soluble polyether-modified silicone wax.
Aspect 10
The cosmetic preparation according to any one of Aspects 1 to 9, which is an infrared protective cosmetic preparation.
本発明によれば、赤外線防御効果に優れて、かつ独特のみずみずしい使用感触を有する化粧料を提供することができる。 The present invention makes it possible to provide a cosmetic product that has excellent infrared protection effects and a unique, refreshing feel when used.
なお、本発明において、「独特のみずみずしい使用感触」とは、化粧料を手指等で皮膚に適用した際に、急激に粘度低下して崩れるような触感があり、それと同時に皮膚に対して広がる非常にみずみずしい感触を与えることを意味する。 In the present invention, the term "unique, fresh feel when used" means that when the cosmetic is applied to the skin with the fingers or the like, the viscosity of the cosmetic drops suddenly and the cosmetic crumbles, and at the same time, the cosmetic gives a very fresh feel as it spreads over the skin.
以下、本発明の実施の形態について詳述する。なお、本発明は、以下の実施の形態に限定されるものではなく、発明の本旨の範囲内で種々変形して実施できる。 The following describes in detail the embodiments of the present invention. Note that the present invention is not limited to the following embodiments, and can be modified in various ways within the scope of the invention.
《水中油型乳化化粧料》
本発明の水中油型乳化化粧料(以下、単に「本発明の化粧料」とも称する)は、
下記成分(a)~(d)を含み:
(a)平均粒子径が500~1500nmであり、かつ表面疎水処理された金属酸化物粒子、
(b)疎水変性アルキルセルロース、
(c)水相増粘剤、及び
(d)油分、
金属酸化物粒子が、油分中に分散されており、かつ
HLB値が10以上のノニオン界面活性剤の含有量が、1.0質量%未満である。
<Oil-in-water emulsion cosmetics>
The oil-in-water emulsion cosmetic of the present invention (hereinafter, also simply referred to as "the cosmetic of the present invention") is
Contains the following components (a) to (d):
(a) metal oxide particles having an average particle size of 500 to 1,500 nm and having a hydrophobic surface;
(b) hydrophobically modified alkyl cellulose;
(c) an aqueous phase thickener; and (d) an oil.
The metal oxide particles are dispersed in an oil component, and the content of a nonionic surfactant having an HLB value of 10 or more is less than 1.0 mass%.
本発明の化粧料は、特有の構成成分を含むこと、及びHLB値が10以上のノニオン界面活性剤の含有量を1.0質量%未満に抑えることによって、本発明の効果を発揮すること、すなわち、赤外線防御効果に優れて、かつ独特のみずみずしい使用感触を有することができる。 The cosmetic product of the present invention exhibits the effects of the present invention by containing specific components and by limiting the content of nonionic surfactants with an HLB value of 10 or more to less than 1.0% by mass, i.e., by providing excellent infrared protection and a unique, refreshing feel when used.
上述した特許文献1の化粧料は、主に紫外線をカットすることを目的としており、平均粒子径が比較的に小さい紫外線散乱剤を使用している。このため、特許文献1では、乳化作用の強いノニオン界面活性剤を使用せずに、比較的に乳化作用が弱い疎水変性アルキルセルロースを使用し、平均粒子径が比較的に小さい紫外線散乱剤を含有する油分を乳化することによって、内油相に疎水性粉末が分散している水中油型乳化化粧料を得ることが開示されている。 The cosmetic of the above-mentioned Patent Document 1 is intended mainly to block ultraviolet rays, and uses an ultraviolet scattering agent with a relatively small average particle size. For this reason, Patent Document 1 discloses that, instead of using a nonionic surfactant with a strong emulsifying effect, a hydrophobically modified alkyl cellulose with a relatively weak emulsifying effect is used to emulsify an oil containing an ultraviolet scattering agent with a relatively small average particle size, thereby obtaining an oil-in-water emulsion cosmetic in which a hydrophobic powder is dispersed in the internal oil phase.
これに対して、平均粒子径が比較的に大きい金属酸化物粒子を含有する油分を乳化することは難しく、一般的には、比較的に乳化作用が強い界面活性剤を多量に配合することが知られている。例えば特許文献2では、含有量1質量%以上の多量のノニオン界面活性剤を、乳化剤として用いて、内油相に疎水性粉末が分散している水中油型乳化化粧料を得ることが開示されている。 On the other hand, it is difficult to emulsify oil containing metal oxide particles with a relatively large average particle size, and it is generally known to incorporate a large amount of a surfactant with a relatively strong emulsifying effect. For example, Patent Document 2 discloses the use of a large amount of a nonionic surfactant with a content of 1% by mass or more as an emulsifier to obtain an oil-in-water emulsion cosmetic in which a hydrophobic powder is dispersed in the internal oil phase.
一方で、本発明者らは、上述した従来の固定観念に捉われず、その鋭意研究によって、乳化が難しいとされていた「平均粒子径が比較的に大きい金属酸化物粒子を含有する油分」の系に対しても、適度な乳化力を有する疎水変性アルキルセルロースを用いて、内油相に疎水性粉末が分散している水中油型乳化化粧料を得ることに成功し、本発明に至った。 On the other hand, the inventors of the present invention have not been limited by the conventional stereotypes mentioned above, and through their intensive research, have succeeded in obtaining an oil-in-water emulsion cosmetic in which a hydrophobic powder is dispersed in the internal oil phase by using a hydrophobically modified alkyl cellulose with a suitable emulsifying power, even in a system of "oil containing metal oxide particles with a relatively large average particle size," which was previously considered difficult to emulsify, and have thus arrived at the present invention.
理論に限定されるものではないが、これは、乳化作用の強い界面活性剤(すなわち、HLB値が10以上のノニオン界面活性剤)を用いる場合には、安定な界面膜を形成可能な一方で、乳化粒子のサイズは比較的小さくなる。したがって、平均粒子径が比較的に大きい金属酸化物粒子は、この乳化粒子のサイズと比較的に近くなり、乳化粒子(油滴)から脱離しやすくなることが考えられる。これに対して、本発明では、疎水変性アルキルセルロースのような比較的に乳化作用が弱い界面活性剤を用いることによって、乳化粒子が比較的大きくなる。したがって、この場合には、平均粒子径が比較的に大きい金属酸化物粒子は、乳化粒子から脱離しにくくなることによると考えられる。 Without being limited to theory, this is because when a surfactant with strong emulsifying power (i.e., a nonionic surfactant with an HLB value of 10 or more) is used, a stable interface film can be formed, but the size of the emulsified particles becomes relatively small. Therefore, it is thought that metal oxide particles with a relatively large average particle size become relatively close to the size of the emulsified particles and are easily detached from the emulsified particles (oil droplets). In contrast, in the present invention, by using a surfactant with a relatively weak emulsifying power such as hydrophobically modified alkyl cellulose, the emulsified particles become relatively large. Therefore, in this case, it is thought that metal oxide particles with a relatively large average particle size are less likely to detach from the emulsified particles.
このように、本発明は、HLB値が10以上のノニオン界面活性剤の含有量を1.0質量%未満に抑えることによって、乳化粒子径のサイズを所望以上に小さくすることなく、安定な内油相に疎水性粉末が分散している水中油型乳化化粧料を得ることだけではなく、多量のノニオン界面活性剤に由来するべたつきの使用感触も抑えることができ、独特のみずみずしい使用感触を得ることができた。 In this way, by limiting the content of nonionic surfactants with an HLB value of 10 or more to less than 1.0 mass%, the present invention not only makes it possible to obtain an oil-in-water emulsion cosmetic in which a hydrophobic powder is dispersed in a stable internal oil phase without making the emulsion particle size smaller than desired, but also suppresses the sticky feel that results from a large amount of nonionic surfactant, resulting in a uniquely fresh feel when used.
なお、本発明の化粧料において、HLB値が10以上のノニオン界面活性剤の含有量は、0.9質量%以下、0.8質量%以下、0.7質量%以下、0.6質量%以下、0.5質量%以下、0.4質量%以下、0.3質量%以下、0.2質量%以下、0.1質量%以下、又は0質量%であってよい。 In addition, in the cosmetic composition of the present invention, the content of the nonionic surfactant having an HLB value of 10 or more may be 0.9% by mass or less, 0.8% by mass or less, 0.7% by mass or less, 0.6% by mass or less, 0.5% by mass or less, 0.4% by mass or less, 0.3% by mass or less, 0.2% by mass or less, 0.1% by mass or less, or 0% by mass.
〈(a)金属酸化物粒子〉
本発明の化粧料に含まれる金属酸化物粒子(以下、単に「本発明の金属酸化物粒子」とも称する)は、平均粒子径が500~1500nmであり、かつ表面疎水処理された金属酸化物粒子である。
(a) Metal Oxide Particles
The metal oxide particles contained in the cosmetic of the present invention (hereinafter also simply referred to as "metal oxide particles of the present invention") have an average particle size of 500 to 1500 nm and are metal oxide particles that have been surface-treated to be hydrophobic.
本発明の金属酸化物粒子は、平均粒子径が500~1500nmであるため、赤外線、特に近赤外線を防御する機能を有する。 The metal oxide particles of the present invention have an average particle size of 500 to 1,500 nm, and therefore have the function of blocking infrared rays, particularly near-infrared rays.
なお、本発明において、「平均粒子径」とは、一次粒子の平均粒子径を指す。 In the present invention, "average particle size" refers to the average particle size of primary particles.
また、本発明において、平均粒子径は、SEM又はTEMによって観察される一次粒子の投影面積円相当径として算出することができる。 In addition, in the present invention, the average particle size can be calculated as the diameter of a circle equivalent to the projected area of the primary particles observed by SEM or TEM.
本発明の金属酸化物粒子は、表面疎水処理されている。ここで、疎水化処理は、疎水化される公知の表面処理剤を用いて行えばよいが、例えば、フッ素化合物処理、シリコーン処理、シリコーン樹脂処理、ペンダント処理、シランカップリング剤処理、チタンカップリング剤処理、油剤処理、N-アシル化リジン処理、ポリアクリル酸処理、イソスタアリン酸処理、金属石鹸処理、アミノ酸処理、無機化合物処理、プラズマ処理、メカノケミカル処理、シラン化合物処理、シラザン化合物処理等が挙げられる。これら処理の中では、分散安定性等の観点から、シリコーン又はシリコーン樹脂による処理、シラン化合物又はシラザン化合物による処理、イソステアリン酸処理が好ましい。 The metal oxide particles of the present invention are surface-hydrophobized. The hydrophobization may be performed using a known surface treatment agent that provides hydrophobization, and examples of such treatment include fluorine compound treatment, silicone treatment, silicone resin treatment, pendant treatment, silane coupling agent treatment, titanium coupling agent treatment, oil treatment, N-acylated lysine treatment, polyacrylic acid treatment, isostearic acid treatment, metal soap treatment, amino acid treatment, inorganic compound treatment, plasma treatment, mechanochemical treatment, silane compound treatment, and silazane compound treatment. Among these treatments, treatment with silicone or silicone resin, treatment with silane compound or silazane compound, and isostearic acid treatment are preferred from the viewpoint of dispersion stability, etc.
本発明の金属酸化物粒子は、表面疎水処理された酸化チタン、表面疎水処理された酸化亜鉛、表面疎水処理された酸化セリウム、又はこれらの混合物等であってもよいが、赤外線領域の遮蔽効果を向上させる観点からは、表面疎水処理された酸化チタンであることが好ましい。 The metal oxide particles of the present invention may be surface-hydrophobically treated titanium oxide, surface-hydrophobically treated zinc oxide, surface-hydrophobically treated cerium oxide, or a mixture thereof, but from the viewpoint of improving the shielding effect in the infrared region, surface-hydrophobically treated titanium oxide is preferred.
本発明の金属酸化物粒子の形状は、特に限定されず、例えば球状、板状、棒状、紡錘状、針状、不定形状等が挙げられる。 The shape of the metal oxide particles of the present invention is not particularly limited, and examples include spherical, plate-like, rod-like, spindle-like, needle-like, and irregular shapes.
なお、本発明の金属酸化物粒子としては、市販されたものを用いてよい。 In addition, commercially available metal oxide particles may be used as the metal oxide particles of the present invention.
また、本発明の金属酸化物粒子としては、金属酸化物粒子がポリヒドロキシステアリン酸等の分散剤で分散された状態の市販品を用いてもよい。 In addition, the metal oxide particles of the present invention may be commercially available products in which the metal oxide particles are dispersed with a dispersant such as polyhydroxystearic acid.
本発明の化粧料において、金属酸化物粒子の含有量は、特に限定されず、例えば1.0質量%以上、1.5質量%以上、2.0質量%以上、2.5質量%以上、3.0質量%以上、3.5質量%以上、4.0質量%以上、4.5質量%以上、5.0質量%以上、5.5質量%以上、6.0質量%以上、6.5質量%以上、7.0質量%以上、7.5質量%以上、8.0質量%以上、8.5質量%以上、9.0質量%以上、9.5質量%以上、又は10.0質量%以上であってもよく、また、30.0質量%以下、20.0質量%以下、又は10.0質量%以下であってもよい。なお、金属酸化物粒子がポリヒドロキシステアリン酸等の分散剤に分散された状態である場合には、ここでいう金属酸化物粒子の含有量は、その固形分の本発明の化粧料における含有量を指す。
In the cosmetic of the present invention, the content of the metal oxide particles is not particularly limited, and may be, for example, 1.0% by mass or more, 1.5% by mass or more, 2.0% by mass or more, 2.5% by mass or more, 3.0% by mass or more, 3.5% by mass or more, 4.0% by mass or more, 4.5% by mass or more, 5.0% by mass or more, 5.5% by mass or more, 6.0% by mass or more, 6.5% by mass or more, 7.0% by mass or more, 7.5% by mass or more, 8.0% by mass or more, 8.5% by mass or more, 9.0% by mass or more, 9.5% by mass or more, or 10.0% by mass or more, or may be 30.0% by mass or less, 20.0% by mass or less, or 10.0% by mass or less. Note that, when the metal oxide particles are in a state of being dispersed in a dispersant such as polyhydroxystearic acid, the content of the metal oxide particles referred to here refers to the content of the solid content in the cosmetic of the present invention.
〈(b)疎水変性アルキルセルロース〉
本発明の化粧料に含まれる疎水変性アルキルセルロースは、「HLB値が10以上のノニオン界面活性剤」に属さないものとし、通常、「高分子界面活性剤」に分類される。
(b) Hydrophobically Modified Alkyl Cellulose
The hydrophobically modified alkyl cellulose contained in the cosmetic composition of the present invention does not belong to the category of "nonionic surfactants having an HLB value of 10 or more" and is generally classified as a "polymeric surfactant."
本発明において、疎水変性アルキルセルロースは、炭素数14~22のアルキル基により疎水変性されたアルキルセルロースを指す。この疎水変性アルキルセルロースは、水溶性セルロースエーテル誘導体に疎水性基である長鎖アルキル基を導入した化合物であり、下記一般式(I)で表される。 In the present invention, hydrophobically modified alkyl cellulose refers to alkyl cellulose that has been hydrophobically modified with an alkyl group having 14 to 22 carbon atoms. This hydrophobically modified alkyl cellulose is a compound in which a long-chain alkyl group, which is a hydrophobic group, has been introduced into a water-soluble cellulose ether derivative, and is represented by the following general formula (I).
式(I)のの疎水変性アルキルセルロースの製造方法は、概ね、基となる水溶性セルロースエーテル誘導体、具体的には、メチルセルロース(Rが水素原子又はメチル基)、エチルセルロース(Rが水素原子又はエチル基)、プロピルセルロース(Rが水素原子又はプロピル基)、ブチルセルロース(Rが水素原子又はブチル基)、ヒドロキシプロピルセルロース[Rが水素原子又はヒドロキシプロピル基(基-[CH2CH(CH3)O]m-H(式中、mは、1~5、好適には1~3の整数である))]、ヒドロキシプロピルメチルセルロース(Rが水素原子、メチル基、又はヒドロキシプロピル基(同上))等に対して、炭素数14~22の長鎖アルキル基導入用化合物、具体的には、下記式(II)の長鎖アルキルグリシジルエーテルを、アルカリ触媒の存在下で接触させて得ることができる。 The method for producing the hydrophobically modified alkyl cellulose of formula (I) generally involves contacting a base water-soluble cellulose ether derivative, specifically methyl cellulose (R is a hydrogen atom or a methyl group), ethyl cellulose (R is a hydrogen atom or an ethyl group), propyl cellulose (R is a hydrogen atom or a propyl group), butyl cellulose (R is a hydrogen atom or a butyl group), hydroxypropyl cellulose [R is a hydrogen atom or a hydroxypropyl group (group -[CH 2 CH(CH 3 )O] m -H (wherein m is an integer of 1 to 5, preferably 1 to 3)], or hydroxypropyl methylcellulose (R is a hydrogen atom, a methyl group, or a hydroxypropyl group (same as above)), with a compound for introducing a long-chain alkyl group having 14 to 22 carbon atoms, specifically a long-chain alkyl glycidyl ether of formula (II) below, in the presence of an alkali catalyst.
本発明の疎水変性アルキルセルロースに導入される基-CH2CH(OH)CH2OR’含有量は、疎水変性アルキルセルロース全体に対して0.1~5.0質量%程度であるのが好ましい。このような含有率とするためには、上記水溶性セルロースエステル誘導体と長鎖アルキルグリシジルエーテルの反応の際のモル比や、反応時間、アルカリ触媒の種類等を適宜選択して製造すればよい。上記反応後、反応物の中和・濾過・洗浄・乾燥・篩分等の精製工程を行ってもよい。 The content of the group -CH 2 CH(OH)CH 2 OR' introduced into the hydrophobically modified alkyl cellulose of the present invention is preferably about 0.1 to 5.0% by mass based on the total amount of the hydrophobically modified alkyl cellulose. In order to achieve such a content, the molar ratio, reaction time, type of alkali catalyst, etc., of the reaction between the water-soluble cellulose ester derivative and the long-chain alkyl glycidyl ether may be appropriately selected for production. After the reaction, the reaction product may be subjected to purification steps such as neutralization, filtration, washing, drying, and sieving.
なお、上記の水溶性セルロースエーテル誘導体のうち、特に、ヒドロキシプロピルメチルセルロースを選択することが好適である(これにより、式(I)におけるRは、水素原子、メチル基、基-[CH2CH(CH3)O]mH、及び、基-CH2CH(OH)CH2OR’の4種のいずれかの基となり、基Aのqが1となり、当該Aはメチレン基となる)。 Among the above water-soluble cellulose ether derivatives, it is particularly preferable to select hydroxypropylmethylcellulose (as a result, R in formula (I) is any one of the four groups of a hydrogen atom, a methyl group, a group -[CH 2 CH(CH 3 )O] m H, and a group -CH 2 CH(OH)CH 2 OR', q of group A is 1, and A is a methylene group).
更に、式(II)の長鎖アルキルグリシジルエーテルにおけるR’は、炭素数14~22のアルキル基、好ましくは炭素数14~20のアルキル基、更に好ましくは炭素数18のステアリル基(-C18H37)である。アルキル基R’の炭素数が14未満又は23以上では、得られた疎水変性アルキルセルロースによる乳化安定性が十分でなくなる。 Furthermore, R' in the long-chain alkyl glycidyl ether of formula (II) is an alkyl group having 14 to 22 carbon atoms, preferably an alkyl group having 14 to 20 carbon atoms, and more preferably a stearyl group ( -C18H37 ) having 18 carbon atoms. If the alkyl group R' has less than 14 carbon atoms or 23 or more carbon atoms, the emulsion stability of the obtained hydrophobically modified alkyl cellulose becomes insufficient.
疎水変性アルキルセルロースの重量平均分子量は、100,000~1000,000が好ましく、より好ましくは300,000~800,000、更に好ましくは550,000~750,000である。 The weight average molecular weight of the hydrophobically modified alkyl cellulose is preferably 100,000 to 1,000,000, more preferably 300,000 to 800,000, and even more preferably 550,000 to 750,000.
本発明において、疎水変性アルキルセルロースとして、疎水変性ヒドロキシプロピルメチルセルロース(疎水化ヒドロキシプロピルメチルセルロース)、より具体的には、ステアロキシヒドロキシプロピルセルロースを用いるのが好ましい。また、疎水変性アルキルセルロースとして、市販品を使用することもでき、例えば、サンジェロース90L(表示名:疎水化ヒドロキシプロピルメチルセルロース;大同化成工業(株)製)、Natrosol Plus 330cs(Ashland社製)、Polysurf 67cs(Ashland社製)等が挙げられるが、これらに限定されない。 In the present invention, it is preferable to use hydrophobically modified hydroxypropyl methylcellulose (hydrophobized hydroxypropyl methylcellulose), more specifically, stearoxy hydroxypropyl cellulose, as the hydrophobically modified alkyl cellulose. In addition, commercially available products can be used as the hydrophobically modified alkyl cellulose, and examples thereof include, but are not limited to, Sangelose 90L (display name: hydrophobized hydroxypropyl methylcellulose; manufactured by Daido Chemical Industry Co., Ltd.), Natrosol Plus 330cs (manufactured by Ashland Co., Ltd.), and Polysurf 67cs (manufactured by Ashland Co., Ltd.).
本発明の化粧料において、疎水変性アルキルセルロースの含有量は、特に限定されず、例えば0.05質量%以上、0.10質量%以上、0.15質量%以上、0.20質量%以上、0.25質量%以上、0.30質量%以上、0.35質量%以上、0.40質量%以上、0.45質量%以上、又は0.50質量%以上であってもよく、また1.0質量%以下、0.80質量%以下、0.50質量%以下、又は0.30質量%以下であってもよい。 In the cosmetic of the present invention, the content of hydrophobically modified alkyl cellulose is not particularly limited, and may be, for example, 0.05% by mass or more, 0.10% by mass or more, 0.15% by mass or more, 0.20% by mass or more, 0.25% by mass or more, 0.30% by mass or more, 0.35% by mass or more, 0.40% by mass or more, 0.45% by mass or more, or 0.50% by mass or more, or 1.0% by mass or less, 0.80% by mass or less, 0.50% by mass or less, or 0.30% by mass or less.
〈(c)水相増粘剤〉
本発明の化粧料に含まれる水相増粘剤は、水相を増粘する機能を有する増粘剤であって、特に、化粧料に一般に配合される範囲の濃度の電解質の存在によって粘度低下を生ずるものであってよい。また、本発明において、このような電解質濃度の上昇により粘度低下が生じる水相増粘剤を「耐塩性の低い水相増粘剤」とも称する。このような耐塩性の低い増粘剤は、従来から化粧料等において水相の粘度調整をする目的で配合されている水溶性増粘剤から選択される。
(c) Aqueous Phase Thickener
The aqueous phase thickener contained in the cosmetic of the present invention is a thickener that has the function of thickening the aqueous phase, and may be one that reduces the viscosity in the presence of electrolytes at concentrations in the range generally used in cosmetics. In the present invention, such aqueous phase thickeners that reduce the viscosity due to an increase in the electrolyte concentration are also referred to as "aqueous phase thickeners with low salt tolerance". Such thickeners with low salt tolerance are selected from water-soluble thickeners that have been conventionally used in cosmetics and the like for the purpose of adjusting the viscosity of the aqueous phase.
具体例としては、ポリビニルアルコール、ポリビニルアセテート、ポリビニルメチルエーテル、ポリビニルピロリドン、ビニルピロリドンとビニルアセテート共重合物、カルボキシビニルポリマー等のビニル系高分子;ポリアクリル酸ナトリウム、ポリエチルアクリレート、ポリアクリル酸アルカノールアミン、アルキルメタクリレートとジメチルアミノエチルメタクリレート共重合物、ポリ2-アクリルアミド-2-メチルプロパンスルホン酸、ポリメタクリロイルオキシトリメチルアンモニウム、(アクリロイルジメチルタウリンアンモニウム/VP)コポリマー、ジメチルアクリルアミド/アクリロイルジメチルタウリンNa)クロスポリマー等のアクリル系高子が挙げられるが、これらに限定されない。 Specific examples include vinyl polymers such as polyvinyl alcohol, polyvinyl acetate, polyvinyl methyl ether, polyvinylpyrrolidone, vinylpyrrolidone and vinyl acetate copolymers, and carboxyvinyl polymers; acrylic polymers such as sodium polyacrylate, polyethyl acrylate, polyacrylic alkanolamine, alkyl methacrylate and dimethylaminoethyl methacrylate copolymers, poly 2-acrylamido-2-methylpropanesulfonic acid, polymethacryloyloxytrimethylammonium, (ammonium acryloyldimethyltaurate/VP) copolymer, and dimethylacrylamide/Na acryloyldimethyltaurate crosspolymer, but are not limited to these.
ただし、耐塩性の低い増粘剤の中でも、ポリマー鎖の絡み合いによって増粘するタイプの増粘剤に比較して、水相中で水膨潤性のミクロゲルを形成して、膨潤したミクロゲル粒子同士の摩擦により増粘するタイプの増粘剤を用いると、化粧料を肌になじませた際のぬるつきを更に抑制できるので好ましい。これは、乳化剤として配合している疎水変性アルキルセルロースがポリマー鎖の絡み合いによる増粘作用も有するため、同じ機構で増粘するタイプの増粘剤を更に配合すると、当該増粘作用が助長されてぬるつきの原因となりうるからである。 However, among thickeners with low salt tolerance, thickeners that form water-swellable microgels in the aqueous phase and thicken due to friction between swollen microgel particles are preferred over thickeners that thicken due to entanglement of polymer chains, as this further suppresses stickiness when the cosmetic is applied to the skin. This is because the hydrophobically modified alkyl cellulose blended as an emulsifier also has a thickening effect due to entanglement of polymer chains, and further blending a thickener that thickens by the same mechanism may promote this thickening effect and cause stickiness.
本発明の化粧料において、水相増粘剤の含有量は、特に限定されず、例えば0.05質量%以上、0.07質量%以上、0.10質量%以上、0.15質量%以上、0.17質量%以上、0.20質量%以上、0.25質量%以上、0.27質量%以上、0.275質量%以上、0.30質量%以上、0.35質量%以上、0.37質量%以上、0.40質量%以上、0.45質量%以上、0.47質量%以上、又は0.50質量%以上であってもよく、また3.0質量%以下、2.0質量%以下、又は1.0質量%以下であってもよい。 In the cosmetic of the present invention, the content of the aqueous phase thickener is not particularly limited, and may be, for example, 0.05% by mass or more, 0.07% by mass or more, 0.10% by mass or more, 0.15% by mass or more, 0.17% by mass or more, 0.20% by mass or more, 0.25% by mass or more, 0.27% by mass or more, 0.275% by mass or more, 0.30% by mass or more, 0.35% by mass or more, 0.37% by mass or more, 0.40% by mass or more, 0.45% by mass or more, 0.47% by mass or more, or 0.50% by mass or more, or 3.0% by mass or less, 2.0% by mass or less, or 1.0% by mass or less.
〈(d)油分〉
本発明の化粧料に含まれる油分は、化粧料等で通常用いられている油性成分から選択される1種又は2種以上とすることができる。
(d) Oil Content
The oil contained in the cosmetic of the present invention can be one or more types selected from oily components commonly used in cosmetics and the like.
本発明の化粧料において、油分の含有量は、特に限定されず、例えば5.0質量%以上、6.0質量%以上、7.0質量%以上、8.0質量%以上、9.0質量%以上、10.0質量%以上、11.0質量%以上、12.0質量%以上、13.0質量%以上、14.0質量%以上、15.0質量%以上、又は16.0質量%以上であってもよく、また40.0質量%以下、30.0質量%以下、又は20.0質量%以下であってもよい。 In the cosmetic of the present invention, the oil content is not particularly limited and may be, for example, 5.0% by mass or more, 6.0% by mass or more, 7.0% by mass or more, 8.0% by mass or more, 9.0% by mass or more, 10.0% by mass or more, 11.0% by mass or more, 12.0% by mass or more, 13.0% by mass or more, 14.0% by mass or more, 15.0% by mass or more, or 16.0% by mass or more, and may be 40.0% by mass or less, 30.0% by mass or less, or 20.0% by mass or less.
本発明において、油分は、特に、極性油を含むことが好ましい。例えば、本発明の化粧料において、油分の55質量%以上、好ましくは60質量%以上、より好ましくは70質量%以上、更に好ましくは80重量%以上が極性油である場合には、乳化安定性を更に向上させることができる。また、油分に占める極性油の割合の上限値は特に限定されず、例えば、極性油が90%以上を占めてもよく、油分の100%が極性油であってもよい。 In the present invention, it is preferable that the oil contains polar oil. For example, in the cosmetic of the present invention, when 55% by weight or more of the oil is polar oil, preferably 60% by weight or more, more preferably 70% by weight or more, and even more preferably 80% by weight or more, the emulsion stability can be further improved. In addition, the upper limit of the proportion of polar oil in the oil is not particularly limited, and for example, polar oil may account for 90% or more, or 100% of the oil may be polar oil.
なお、本発明において、「極性油」は、化粧料に一般に使用される油分の中で極性が高いものであれば特に限定されないが、例えば、比誘電率が約5以上、好ましくは約10以上の油が好ましく用いられる。 In the present invention, the "polar oil" is not particularly limited as long as it is an oil that is generally used in cosmetics and has a high polarity, but for example, an oil with a relative dielectric constant of about 5 or more, preferably about 10 or more, is preferably used.
極性油の代表例としては、エステル油及び紫外線吸収剤が挙げられる。また、従来の化粧料より多量の極性油を含んでいることにより、例えば高極性の香料等も安定に配合することができる。 Typical examples of polar oils include ester oils and UV absorbers. In addition, because it contains a larger amount of polar oil than conventional cosmetics, it is possible to stably incorporate, for example, highly polar fragrances.
(エステル油)
本発明において、極性油として使用されうるエステル油の具体例には、ジネオペンタン酸トリプロピレングリコール、イソノナン酸イソノニル、ミリスチン酸イソプロピル、オクタン酸セチル、ミリスチン酸オクチルドデシル、パルミチン酸イソプロピル、ステアリン酸ブチル、ラウリン酸ヘキシル、ミリスチン酸ミリスチル、オレイン酸デシル、ジメチルオクタン酸ヘキシルデシル、乳酸セチル、乳酸ミリスチル、酢酸ラノリン、ステアリン酸イソセチル、イソステアリン酸イソセチル、12-ヒドロキシステアリン酸コレステリル、エチルヘキサン酸セチル、ジ-2-エチルヘキサン酸エチレングリコール、ジペンタエリスリトール脂肪酸エステル、モノイソステアリン酸N-アルキルグリコール、ジカプリン酸ネオペンチルグリコール、リンゴ酸ジイソステアリル、ジ-2-ヘプチルウンデカン酸グリセリン、トリ-2-エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ-2-エチルヘキサン酸ペンタエリスリチル、トリエチルヘキサノイン(トリ-2-エチルヘキサン酸グリセリン)、トリオクタン酸グリセリン、トリイソパルミチン酸グリセリン、トリイソステアリン酸トリメチロールプロパン、セチル2-エチルヘキサノエート、2-エチルヘキシルパルミテート、トリミリスチン酸グリセリン、トリ-2-ヘプチルウンデカン酸グリセライド、ヒマシ油脂肪酸メチルエステル、オレイン酸オレイル、アセトグリセライド、パルミチン酸2-ヘプチルウンデシル、アジピン酸ジイソブチル、N-ラウロイル-L-グルタミン酸-2-オクチルドデシルエステル、アジピン酸ジ-2-ヘプチルウンデシル、エチルラウレート、セバシン酸ジ-2-エチルヘキシル、ミリスチン酸2-ヘキシルデシル、パルミチン酸2-ヘキシルデシル、アジピン酸2-ヘキシルデシル、セバシン酸ジイソプロピル、コハク酸2-エチルヘキシル、及びクエン酸トリエチル等が挙げられるが、これらに限定されない。
(Ester oil)
Specific examples of ester oils that can be used as polar oils in the present invention include tripropylene glycol dineopentanoate, isononyl isononanoate, isopropyl myristate, cetyl octanoate, octyldodecyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, myristyl myristate, decyl oleate, hexyldecyl dimethyloctanoate, cetyl lactate, myristyl lactate, lanolin acetate, isocetyl stearate, isocetyl isostearate, cholesteryl 12-hydroxystearate, cetyl ethylhexanoate, ethylene glycol di-2-ethylhexanoate, dipentaerythritol fatty acid esters, N-alkyl glycol monoisostearate, neopentyl glycol dicaprate, diisostearyl malate, glycerin di-2-heptylundecanoate, trimethylolpropane tri-2-ethylhexanoate, trimethylolpropane triisostearate, tetra- Pentaerythrityl 2-ethylhexanoate, triethylhexanoin (tri-2-ethylhexanoic acid glycerin), trioctanoic acid glycerin, triisopalmitic acid glycerin, triisostearate trimethylolpropane, cetyl 2-ethylhexanoate, 2-ethylhexyl palmitate, trimyristate glycerin, tri-2-heptylundecanoic acid glyceride, castor oil fatty acid methyl ester, oleyl oleate, acetoglyceride, palmitic acid Examples of the oleic acid ester include, but are not limited to, 2-heptylundecyl oleate, diisobutyl adipate, N-lauroyl-L-glutamic acid-2-octyldodecyl ester, di-2-heptylundecyl adipate, ethyl laurate, di-2-ethylhexyl sebacate, 2-hexyldecyl myristate, 2-hexyldecyl palmitate, 2-hexyldecyl adipate, diisopropyl sebacate, 2-ethylhexyl succinate, and triethyl citrate.
(紫外線吸収剤)
本発明において、極性油として使用されうる紫外線吸収剤の具体例には、安息香酸誘導体、サリチル酸誘導体、ケイ皮酸誘導体、ジベンゾイルメタン誘導体、β,β-ジフェニルアクリラート誘導体、ベンゾフェノン誘導体、ベンジリデンショウノウ誘導体、フェニルベンゾイミダゾール誘導体、トリアジン誘導体、フェニルベンゾトリアゾール誘導体、アントラニル誘導体、イミダゾリン誘導体、ベンザルマロナート誘導体、4,4-ジアリールブタジエン誘導体等が挙げられるが、これらに限定されない。また、以下にこれらのいくつかの具体例及び商品名等を例示的に説明する。
(Ultraviolet absorber)
In the present invention, specific examples of ultraviolet absorbers that can be used as polar oils include, but are not limited to, benzoic acid derivatives, salicylic acid derivatives, cinnamic acid derivatives, dibenzoylmethane derivatives, β,β-diphenylacrylate derivatives, benzophenone derivatives, benzylidene camphor derivatives, phenylbenzimidazole derivatives, triazine derivatives, phenylbenzotriazole derivatives, anthranil derivatives, imidazoline derivatives, benzalmalonate derivatives, 4,4-diarylbutadiene derivatives, etc. Some specific examples and trade names of these will be described below as examples.
安息香酸誘導体としては、例えばパラ-アミノ安息香酸(PABA)エチル、エチル-ジヒドロキシプロピルPABA、エチルヘキシル-ジメチルPABA(例えば「エスカロール507」;ISP社製)、グリセリルPABA、PEG-25-PABA(例えば「ユビナールP25」;BASF社製)、及びジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル(例えば「ユビナールAプラス」)等が挙げられるが、これらに限定されない。 Examples of benzoic acid derivatives include, but are not limited to, ethyl para-aminobenzoate (PABA), ethyl-dihydroxypropyl PABA, ethylhexyl-dimethyl PABA (e.g., Escarol 507; manufactured by ISP), glyceryl PABA, PEG-25-PABA (e.g., Uvinal P25; manufactured by BASF), and diethylaminohydroxybenzoylhexyl benzoate (e.g., Uvinal A Plus).
サリチル酸誘導体としては、ホモサレート(「ユーソレックス(Eusolex)HMS」;ロナ/EMインダストリーズ社製)、エチルヘキシルサリチレート(例えば「ネオ・ヘリオパン(NeoHeliopan)OS」;ハーマン・アンド・レイマー社製)、ジプロピレングリコールサリチレート(例えば「ディピサル(Dipsal)」;スケル社製)、及びTEAサリチラート(例えば「ネオ・ヘリオパンTS」;ハーマン・アンド・レイマー社製)等が挙げられるが、これらに限定されない。 Salicylic acid derivatives include, but are not limited to, homosalate (Eusolex HMS; Rona/EM Industries), ethylhexyl salicylate (e.g., NeoHeliopan OS; Herman & Reimer), dipropylene glycol salicylate (e.g., Dipsal; Skel), and TEA salicylate (e.g., NeoHeliopan TS; Herman & Reimer).
ケイ皮酸誘導体としては、メトキシケイヒ酸エチルヘキシル(例えば「パルソールMCX」;ホフマン-ラ・ロシュ社製)、メトキシケイ皮酸イソプロピル、メトキシケイ皮酸イソアミル(例えば「ネオ・ヘリオパンE1000」; ハーマン・アンド・レイマー社製)、シンノキセート、DEAメトキシシンナメート、メチルケイ皮酸ジイソプロピル、グリセリル-エチルヘキサノエート-ジメトキシシンナメート、及びジ-(2-エチルヘキシル)-4'-メトキシベンザルマロネート等が挙げられるが、これらに限定されない。 Cinnamic acid derivatives include, but are not limited to, ethylhexyl methoxycinnamate (e.g., Parsol MCX, manufactured by Hoffmann-La Roche), isopropyl methoxycinnamate, isoamyl methoxycinnamate (e.g., Neo Heliopan E1000, manufactured by Herman & Reimer), cinnoxate, DEA methoxycinnamate, diisopropyl methylcinnamate, glyceryl-ethylhexanoate-dimethoxycinnamate, and di-(2-ethylhexyl)-4'-methoxybenzalmalonate.
ジベンゾイルメタン誘導体としては、4-tert-ブチル-4’-メトキシジベンゾイルメタン(例えば「パルソール1789」)等が挙げられるが、これらに限定されない。 Dibenzoylmethane derivatives include, but are not limited to, 4-tert-butyl-4'-methoxydibenzoylmethane (e.g., Parsol 1789).
β,β-ジフェニルアクリレート誘導体としては、オクトクリレン(例えば「ユビナールN539」;BASF社製)等が挙げられるが、これらに限定されない。 Examples of β,β-diphenylacrylate derivatives include, but are not limited to, octocrylene (e.g., "Uvinal N539" manufactured by BASF).
ベンゾフェノン誘導体としては、ベンゾフェノン-1(例えば「ユビナール400」;BASF社製)、ベンゾフェノン-2(例えば「ユビナールD50」;BASF社製)、ベンゾフェノン-3またはオキシベンゾン(例えば「ユビナールM40」;BASF社製)、ベンゾフェノン-4(例えば「ユビナールMS40」;BASF社製)、ベンゾフェノン-5、ベンゾフェノン-6(例えば「ヘリソーブ(Helisorb)11」;ノルクアイ社)、ベンゾフェノン-8(例えば「スペクトラ-ソーブ(Spectra-Sorb)UV-24」;アメリカン・シアナミド社製)、ベンゾフェノン-9(例えば「ユビナールDS-49」;BASF社製)、及びベンゾフェノン-12等が挙げられるが、これらに限定されない。 Benzophenone derivatives include, but are not limited to, benzophenone-1 (e.g., "Uvinal 400"; manufactured by BASF), benzophenone-2 (e.g., "Uvinal D50"; manufactured by BASF), benzophenone-3 or oxybenzone (e.g., "Uvinal M40"; manufactured by BASF), benzophenone-4 (e.g., "Uvinal MS40"; manufactured by BASF), benzophenone-5, benzophenone-6 (e.g., "Helisorb 11"; manufactured by Norquay), benzophenone-8 (e.g., "Spectra-Sorb UV-24"; manufactured by American Cyanamid), benzophenone-9 (e.g., "Uvinal DS-49"; manufactured by BASF), and benzophenone-12.
ベンジリデンショウノウ誘導体としては、3-ベンジリデンショウノウ(例えば「メギゾリル(Mexoryl)SD」;シメックス社製)、4-メチルベンジリデンショウノウ、ベンジリデンショウノウスルホン酸(例えば「メギゾリルSL」;シメックス社製)、メト硫酸ショウノウベンザルコニウム(例えば「メギゾリルSO」;シメックス社製)、テレフタリリデンジショウノウスルホン酸(例えば「メギゾリルSX」;シメックス社製)、及びポリアクリルアミドメチルベンジリデンショウノウ(例えば「メギゾリルSW」;シメックス社製)等が挙げられるが、これらに限定されない。 Examples of benzylidene camphor derivatives include, but are not limited to, 3-benzylidene camphor (e.g., "Mexoryl SD"; manufactured by Symex), 4-methylbenzylidene camphor, benzylidene camphor sulfonic acid (e.g., "Mexoryl SL"; manufactured by Symex), camphor benzalkonium methosulfate (e.g., "Mexoryl SO"; manufactured by Symex), terephthalide discamphor sulfonic acid (e.g., "Mexoryl SX"; manufactured by Symex), and polyacrylamide methyl benzylidene camphor (e.g., "Mexoryl SW"; manufactured by Symex).
フェニルベンゾイミダゾール誘導体としては、フェニルベンゾイミダゾールスルホン酸(例えば「ユーソレックス232」;メルク社製)、及びフェニルジベンゾイミダゾールテトラスルホン酸二ナトリウム(例えば「ネオ・ヘリオパンAP」;ハーマン・アンド・レイマー社製)等が挙げられるが、これらに限定されない。 Examples of phenylbenzimidazole derivatives include, but are not limited to, phenylbenzimidazole sulfonic acid (e.g., "Eusolex 232" manufactured by Merck) and disodium phenyldibenzimidazole tetrasulfonate (e.g., "Neo Heliopan AP" manufactured by Herman & Reimer).
トリアジン誘導体としては、アニソトリアジン(例えば「チノソーブ(Tinosorb)S」;チバ・スペシャリティー・ケミカルズ社製)、エチルヘキシルトリアゾン(例えば「ユビナールT150」;BASF社製)、ジエチヘキシルブタミドトリアゾン(例えば「ユバソーブ(Uvasorb)HEB」;シグマ3V社製)、及び2,4,6-トリス(ジイソブチル-4’-アミノベンザルマロナート)-s-トリアジン等が挙げられるが、これらに限定されない。 Examples of triazine derivatives include, but are not limited to, anisotriazine (e.g., "Tinosorb S" manufactured by Ciba Specialty Chemicals), ethylhexyl triazone (e.g., "Uvinal T150" manufactured by BASF), diethylhexylbutamido triazone (e.g., "Uvasorb HEB" manufactured by Sigma 3V), and 2,4,6-tris(diisobutyl-4'-aminobenzalmalonate)-s-triazine.
フェニルベンゾトリアゾール誘導体としては、ドロメトリゾールトリシロキサン(例えば「シラトリゾール(Silatrizole)」;ローディア・シミー社製)、及びメチレンビス(ベンゾトリアゾリルテトラメチルブチルフェノール)(例えば「チノソーブM」(チバ・スペシャリティー・ケミカルズ社製))等が挙げられるが、これらに限定されない。 Examples of phenylbenzotriazole derivatives include, but are not limited to, drometrizole trisiloxane (e.g., Silatrizole, manufactured by Rhodia-Chemie), and methylene bis(benzotriazolyl tetramethylbutylphenol) (e.g., Tinosorb M, manufactured by Ciba Specialty Chemicals).
アントラニル誘導体としては、アントラニル酸メンチル(例えば「ネオ・ヘリオパンMA」;ハーマン・アンド・レイマー社製)等が挙げられるが、これらに限定されない。 Anthranil derivatives include, but are not limited to, menthyl anthranilate (e.g., "Neo Heliopan MA" manufactured by Herman & Reimer).
イミダゾリン誘導体としては、エチルヘキシルジメトキシベンジリデンジオキソイミダゾリンプロピオナート等が挙げられるが、これらに限定されない。 Imidazoline derivatives include, but are not limited to, ethylhexyl dimethoxybenzylidene dioxoimidazoline propionate.
ベンザルマロナート誘導体としては、ベンザルマロナート官能基を有するポリオルガノシロキサン(例えば、ポリシリコーン-15;「パルソールSLX」;DSMニュートリション ジャパン社製)等が挙げられるが、これらに限定されない。 Benzalmalonate derivatives include, but are not limited to, polyorganosiloxanes having benzalmalonate functional groups (e.g., polysilicone-15; "Parsol SLX"; manufactured by DSM Nutrition Japan).
4,4-ジアリールブタジエン誘導体としては、1,1-ジカルボキシ(2,2’-ジメチルプロピル)-4,4-ジフェニルブタジエン等が挙げられるが、これらに限定されない。 Examples of 4,4-diarylbutadiene derivatives include, but are not limited to, 1,1-dicarboxy(2,2'-dimethylpropyl)-4,4-diphenylbutadiene.
〈その他の成分〉
本発明の化粧料は、上述した必須成分(a)~(d)に加え、本発明の効果を損なわない範囲でその他の成分を更に含んでよい。以下では、その他の成分について、例示的に説明する。
<Other Ingredients>
In addition to the essential components (a) to (d) described above, the cosmetic preparation of the present invention may further contain other components within the scope of not impairing the effects of the present invention. The other components will be described below by way of example.
((e)ポリヒドロキシステアリン酸)
本発明の化粧料は、ポリヒドロキシステアリン酸を更に含んでよい。ポリヒドロキシステアリン酸は、本発明の金属酸化物粒子を油分中に均一に分散させる効果を有する観点から、好ましい。
(e) Polyhydroxystearic acid
The cosmetic composition of the present invention may further contain polyhydroxystearic acid. Polyhydroxystearic acid is preferred from the viewpoint of having the effect of uniformly dispersing the metal oxide particles of the present invention in oil.
ポリヒドロキシステアリン酸は、ヒドロキシステアリン酸がエステル結合を形成することで、オリゴマー化した化合物であり、市販のものとしては、例えばHSオリゴマー600(豊国製油株式会社製)、及びサラコスHS-6C(日清オイリオ社製)等が販売されており、これらを使用することができる。また、ポリヒドロキシステアリン酸は、重合度を特に限定されず、例えば4~8であってよい。 Polyhydroxystearic acid is a compound in which hydroxystearic acid is oligomerized by forming an ester bond, and commercially available products include, for example, HS Oligomer 600 (manufactured by Toyokuni Oil Mills Co., Ltd.) and Salacos HS-6C (manufactured by Nisshin Oillio Co., Ltd.), which can be used. There are no particular limitations on the degree of polymerization of polyhydroxystearic acid, and it may be, for example, 4 to 8.
本発明の化粧料において、ポリヒドロキシステアリン酸を含む場合のポリヒドロキシステアリン酸の含有量は、例えば0.01~3.0質量%、0.05~2.0質量%、又は0.10~1.0質量%であってよい。 In the cosmetic composition of the present invention, when polyhydroxystearic acid is contained, the content of polyhydroxystearic acid may be, for example, 0.01 to 3.0% by mass, 0.05 to 2.0% by mass, or 0.10 to 1.0% by mass.
((f)イオン界面活性剤)
本発明の化粧料は、イオン界面活性剤を更に含んでよい。イオン界面活性剤は、静電反発が働き、乳化粒子同士が合一することを防ぐ観点から、好ましい。
((f) Ionic Surfactant)
The cosmetic preparation of the present invention may further contain an ionic surfactant. The ionic surfactant is preferred from the viewpoint of preventing the emulsion particles from coalescing due to electrostatic repulsion.
イオン界面活性剤は、水に溶解した場合にイオンに解離する界面活性剤であり、具体的には、アニオン界面活性剤、カチオン界面活性剤、及び両性界面活性剤等に分類している。 Ionic surfactants are surfactants that dissociate into ions when dissolved in water, and are specifically classified into anionic surfactants, cationic surfactants, amphoteric surfactants, etc.
イオン界面活性剤としては、例えばN-ステアロイル-N-メチルタウリン、N-ステアロイル-N-メチルタウリンナトリウムN-ステアロイル-L-グルタミン酸二ナトリウム、N-ステアロイル-L-グルタミン酸ナトリウム、ポリオキシエチレンラウリルエーテル酢酸ナトリウム、ポリオキシエチレンラウリルエーテル酢酸トリエタノールアミン、ラウリン酸タウリンナトリウム、ラウロイルメチルタウリンナトリウム、ラウリン酸トリエタノールアミン等のアニオン界面活性剤;ステアリルジメチルアミンオキサイド、塩化ステアリルトリメチルアンモニウム等のカチオン界面活性剤;ラウリルジメチルベタイン、ラウリルジメチルアミノ酢酸ベタイン等の両性界面活性剤等が挙げられるが、これらに限定されない。 Examples of ionic surfactants include anionic surfactants such as N-stearoyl-N-methyl taurine, sodium N-stearoyl-N-methyl taurine, disodium N-stearoyl-L-glutamate, sodium N-stearoyl-L-glutamate, sodium polyoxyethylene lauryl ether acetate, polyoxyethylene lauryl ether acetate triethanolamine, sodium laurate taurine, sodium lauroyl methyl taurine, and triethanolamine laurate; cationic surfactants such as stearyl dimethylamine oxide and stearyl trimethylammonium chloride; and amphoteric surfactants such as lauryl dimethyl betaine and lauryl dimethyl amino acetate betaine, but are not limited to these.
本発明の化粧料において、イオン界面活性剤を含む場合のイオン界面活性剤の含有量は、例えば0.01~2.0質量%、0.05~1.0質量%、又は0.10~0.50質量%であってよい。 In the cosmetic composition of the present invention, when an ionic surfactant is contained, the content of the ionic surfactant may be, for example, 0.01 to 2.0% by mass, 0.05 to 1.0% by mass, or 0.10 to 0.50% by mass.
(その他の界面活性剤)
本発明の化粧料は、ノニオン界面活性剤(「非イオン界面活性剤」)に関しては、HLB値が10以上のノニオン界面活性剤の含有量が1.0質量%未満であるという条件を満たせば、HLB値が10未満のノニオン界面活性剤を含んでもよい。
(Other surfactants)
With regard to nonionic surfactants ("nonionic surfactants"), the cosmetic preparation of the present invention may contain a nonionic surfactant with an HLB value of less than 10, so long as the content of nonionic surfactants with an HLB value of 10 or more is less than 1.0 mass%.
HLB値が10未満のノニオン界面活性剤としては、例えば、ビスブチルジメチコンポリグリセリル-3(HLB値:0.5)、PEG-10ジメチコン(HLB値:2.0)、又はPEG-9ポリジメチルシロキシエチルジメチコン(HLB値:4.0)等が挙げられるが、これらに限定されない。 Examples of nonionic surfactants with an HLB value of less than 10 include, but are not limited to, bisbutyldimethicone polyglyceryl-3 (HLB value: 0.5), PEG-10 dimethicone (HLB value: 2.0), and PEG-9 polydimethylsiloxyethyl dimethicone (HLB value: 4.0).
本発明の化粧料において、HLB値が10未満のノニオン界面活性剤を更に含む場合のその含有量は、例えば0.01~2.0質量%、又は0.05~1.0質量%であってよい。 When the cosmetic composition of the present invention further contains a nonionic surfactant with an HLB value of less than 10, the content of the nonionic surfactant may be, for example, 0.01 to 2.0% by mass, or 0.05 to 1.0% by mass.
また、上述した界面活性剤以外に、例えば高分子界面活性剤、又は天然界面活性剤等も本発明の効果を損なわない限り、本発明の化粧料に更に配合してもよい。 In addition to the above-mentioned surfactants, for example, polymeric surfactants or natural surfactants may be further blended into the cosmetic composition of the present invention as long as they do not impair the effects of the present invention.
((g)水溶性ポリエーテル変性シリコーンワックス)
本発明の化粧料は、水溶性ポリエーテル変性シリコーンワックスを更に含んでよい。水溶性ポリエーテル変性シリコーンワックスは、本発明の化粧料をべたつきがなく、乳化安定性を更によくし、かつさっぱりとした乳化物にする効果がある観点から、好ましい。
((g) Water-soluble polyether modified silicone wax)
The cosmetic of the present invention may further contain a water-soluble polyether-modified silicone wax. The water-soluble polyether-modified silicone wax is preferred from the viewpoint of making the cosmetic of the present invention non-sticky, further improving the emulsion stability, and providing a refreshing emulsion.
水溶性ポリエーテル変性シリコーンワックスとしては、例えばビスPEG-18メチルエーテルジメチルシラン、ビスPEG-15メチルエーテルジメチコン、PEG-32メチルエーテルジメチコン、及びPEG-17ジメチコン等が挙げられるが、これらに限定されない。 Examples of water-soluble polyether-modified silicone waxes include, but are not limited to, bisPEG-18 methyl ether dimethyl silane, bisPEG-15 methyl ether dimethicone, PEG-32 methyl ether dimethicone, and PEG-17 dimethicone.
また、水溶性ポリエーテル変性シリコーンワックスは市販品から入手することができ、例えばCosmeticWax2501(東レ・ダウコーニング株式会社製、ビスPEG-18メチルエーテルジメチルシラン、融点36~42℃)、DMC 6038(ワッカー社製、ビスPEG-15メチルエーテルジメチコン、融点約30℃)、KF-6004(信越化学工業株式会社製、PEG-32メチルエーテルジメチコン、融点45℃)、及びSilsoft(登録商標)895(MOMENTIVE社製、PEG-17ジメチコン)等が挙げられるが、これらに限定されない。 Water-soluble polyether-modified silicone waxes can be obtained commercially, and examples include, but are not limited to, CosmeticWax 2501 (manufactured by Dow Corning Toray Co., Ltd., bisPEG-18 methyl ether dimethylsilane, melting point 36 to 42°C), DMC 6038 (manufactured by Wacker, bisPEG-15 methyl ether dimethicone, melting point approximately 30°C), KF-6004 (manufactured by Shin-Etsu Chemical Co., Ltd., PEG-32 methyl ether dimethicone, melting point 45°C), and Silsoft (registered trademark) 895 (manufactured by MOMENTIVE, PEG-17 dimethicone).
本発明の化粧料において、水溶性ポリエーテル変性シリコーンワックスを含む場合の水溶性ポリエーテル変性シリコーンワックスの含有量は、例えば0.1~20.0質量%、0.5~15.0質量%、又は1.0~10.0質量%であってよい。 In the cosmetic composition of the present invention, when the cosmetic composition contains a water-soluble polyether-modified silicone wax, the content of the water-soluble polyether-modified silicone wax may be, for example, 0.1 to 20.0% by mass, 0.5 to 15.0% by mass, or 1.0 to 10.0% by mass.
((h)清涼化剤)
本発明の化粧料は、清涼化剤を更に含んでよい。清涼化剤は、清涼感を高める観点から、好ましい。
(h) Cooling Agents
The cosmetic preparation of the present invention may further contain a cooling agent. The cooling agent is preferable from the viewpoint of enhancing a feeling of coolness.
清涼化剤としては、メントール、ハッカ油、l-メンチルグリセリルエーテル、乳酸メンチル、カンファー、イソプレゴール、ボルネオロール、シネオールメントン、スペアミント、ペパーミント、マロン酸メンチル、グリコシル-モノ-メンチル-O-アセテート、3-L-メントキシプロパン-1,2-ジオール、及び1-メンチル-3-ヒドロキシブチレートからなる群から選択される1以上を用いてよい。 The cooling agent may be one or more selected from the group consisting of menthol, peppermint oil, l-menthyl glyceryl ether, menthyl lactate, camphor, isopulegol, bornol, cineole menthone, spearmint, peppermint, menthyl malonate, glycosyl-mono-menthyl-O-acetate, 3-L-menthoxypropane-1,2-diol, and 1-menthyl-3-hydroxybutyrate.
本発明の化粧料において、清涼化剤を含む場合の水清涼化剤の含有量は、例えば0.1~10.0質量%、0.5~10.0質量%、又は1.0~5.0質量%であってよい。 In the cosmetic composition of the present invention, when a water refreshing agent is included, the content of the water refreshing agent may be, for example, 0.1 to 10.0% by mass, 0.5 to 10.0% by mass, or 1.0 to 5.0% by mass.
上述した「その他の成分」以外には、本発明の化粧料は、例えばプロピレングリコール、ジプロピレングリコール、1,3-ブチレングリコール、1,4-ブチレングリコール、ジエチレングリコール、トリエチレングリコール、ポリエチレングリコール等のグリコール類;グリセリン、ジグリセリン、ポリグリセリン等のグリセリン類;ソルビトール、マンニトール、マルチトール、キシリトール、エリスリトール等の糖アルコール類;フルクトース、グルコース、ガラクトース、マルトース、ラクトース、トレハロース等の糖類;クロロフィル、β-カロチン等の天然色素;アラビアガム、トラガントガム、ガラクタン、グアガム、キャロブガム、カラヤガム、ジェランガム、カラギーナン等の植物系高分子;キサンタンガム、デキストラン、サクシノグルカン、プルラン等の微生物系高分子;コラーゲン、カゼイン、アルブミン、ゼラチン等の動物系高分子;カルボキシメチルデンプン、メチルヒドロキシプロピルデンプン等のデンプン系高分子;メチルセルロース、エチルセルロース、メチルヒドロキシプロピルセルロース、ヒドロキシエチルセルロース、セルロース硫酸ナトリウム、ヒドロキシプロピルセルロース、カルボキシメチルセルロースナトリウム、結晶セルロース等のセルロース系高分子;アルギン酸ナトリウム、アルギン酸プロピレングリコールエステル等のアルギン酸系高分子;その他の増粘剤;アスコルビン酸リン酸マグネシウム、アスコルビン酸グルコシド、ビタミンB6塩酸塩、パントテニルエチルエーテル等のビタミン類;殺菌剤、消炎剤、防腐剤、植物抽出液、アミノ酸等の薬剤;エタノール、イソプロピルアルコール等の低級アルコール;フェノキシエタノール、ベンジルアルコール等の芳香族アルコール;又はシリカ等の化粧料に通常配合されている各種成分も更に含んでよい。 In addition to the "other ingredients" described above, the cosmetic composition of the present invention may contain, for example, glycols such as propylene glycol, dipropylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, diethylene glycol, triethylene glycol, and polyethylene glycol; glycerins such as glycerin, diglycerin, and polyglycerin; sugar alcohols such as sorbitol, mannitol, maltitol, xylitol, and erythritol; sugars such as fructose, glucose, galactose, maltose, lactose, and trehalose; natural pigments such as chlorophyll and β-carotene; plant-based polymers such as gum arabic, gum tragacanth, galactan, guar gum, carob gum, karaya gum, gellan gum, and carrageenan; microbial polymers such as xanthan gum, dextran, succinoglucan, and pullulan; and animal-based polymers such as collagen, casein, albumin, and gelatin. starch-based polymers such as carboxymethyl starch and methylhydroxypropyl starch; cellulose-based polymers such as methylcellulose, ethylcellulose, methylhydroxypropylcellulose, hydroxyethylcellulose, sodium cellulose sulfate, hydroxypropylcellulose, sodium carboxymethylcellulose, and crystalline cellulose; alginic acid-based polymers such as sodium alginate and propylene glycol alginate; other thickeners; vitamins such as magnesium ascorbyl phosphate, ascorbyl glucoside, vitamin B6 hydrochloride, and pantothenyl ethyl ether; drugs such as bactericides, anti-inflammatory agents, preservatives, plant extracts, and amino acids; lower alcohols such as ethanol and isopropyl alcohol; aromatic alcohols such as phenoxyethanol and benzyl alcohol; or silica, and other various components that are usually incorporated into cosmetics.
本発明の化粧料は、水中油型乳化化粧料に通常用いられている方法に従って調製することができる。即ち、水相成分及び油相成分を別々に混合し、水相成分を攪拌しながら油相成分を添加して乳化することによって調製できる。 The cosmetic of the present invention can be prepared according to a method commonly used for oil-in-water emulsion cosmetics. That is, the cosmetic can be prepared by mixing the aqueous phase component and the oil phase component separately, and emulsifying the aqueous phase component by adding the oil phase component while stirring the aqueous phase component.
本発明の化粧料は、特に限定されるものではないが、平均7.5μm、最大で約20μmの乳化粒子径を有してよい。なお、乳化粒子径は、例えば、顕微鏡を用いて、乳化粒子の大きさ(マイクロメーターによる測定)及びその分布状況(検鏡視野の粒子の均一度)を肉眼で総合的に判定することによって、求めることができる。 The cosmetic of the present invention may have an emulsion particle size of 7.5 μm on average and approximately 20 μm at maximum, but is not particularly limited to this size. The emulsion particle size can be determined, for example, by using a microscope to comprehensively determine the size of the emulsion particles (measured with a micrometer) and their distribution (uniformity of particles in the field of view) with the naked eye.
本発明の化粧料は、上述した本発明の効果を発揮できるため、赤外防御化粧料であってよい。 The cosmetic of the present invention may be an infrared protective cosmetic since it can exert the effects of the present invention described above.
以下に実施例を挙げて、本発明について更に詳しく説明を行うが、本発明はこれらに限定されるものではない。なお、以下、特に断りのない限り、含有量は質量%で示す。 The present invention will be described in more detail below with reference to examples, but the present invention is not limited to these. In the following, the contents are shown in mass % unless otherwise specified.
下記の表1に示す処方で、実施例及び比較例の化粧料を調製し、得られた各化粧料について、安定性、赤外線カット率、使用感、及び乳化粒子径を、以下の基準に従って評価して、それらの結果を表2示す。 The cosmetics of the examples and comparative examples were prepared according to the formulations shown in Table 1 below, and the stability, infrared cut rate, usability, and emulsion particle size of each obtained cosmetic were evaluated according to the following criteria, and the results are shown in Table 2.
〈安定性〉
実施例及び比較例で得られた各化粧料を、2本のスクリュー管(50ml)に充填し、0℃又は50℃の恒温槽に2週間静置した。静置の前後に回転式粘度計(ビスメトロン回転式粘度計)を用いて粘度変化を測定するとともに、乳化粒子、外観の観測を行った:
「評価基準」
「A」:0℃、50℃のいずれの温度水準においても粘度低下が見られず、乳化粒子、外観に問題がなかった。
「B」:いずれかの温度水準にて、若干の粘度低下または乳化粒子の増大、外観の変化が観察された。
「C」:いずれかの温度水準にて、金属酸化物粒子の飛び出しが観察された。
Stability
Each of the cosmetics obtained in the Examples and Comparative Examples was filled into two screw tubes (50 ml) and left to stand for two weeks in a thermostatic bath at 0° C. or 50° C. Before and after standing, the change in viscosity was measured using a rotational viscometer (Vismetron rotational viscometer), and the emulsion particles and appearance were observed:
"Evaluation Criteria"
"A": No decrease in viscosity was observed at either temperature level of 0°C or 50°C, and there were no problems with the emulsion particles or appearance.
"B": At any temperature level, a slight decrease in viscosity, an increase in emulsified particles, or a change in appearance was observed.
"C": Protrusion of metal oxide particles was observed at any temperature level.
〈赤外線カット率〉
実施例及び比較例で得られた各化粧料を、PMMA(ポリメタクリル酸メチル樹脂)基板(HelioScreen社製HD6)に塗布し、15分間乾燥させ、測定用の試料とした。また、何も塗布していないPMMA基板を対照用の試料とした。測定用試料、対照用試料それぞれについて分光光度計(島津製作所社製UV-3600、積分球モード)にて1500nmの透過率を測定した。測定の際には、積分球の開口部の外縁にPMMA基板の塗工面を、両面テープを用いて密着させた。測定用試料の透過率を対照用試料の透過率で除した値を透過率とし、(100%-透過率)を赤外線カット率(%)とした。
<Infrared blocking rate>
Each cosmetic obtained in the examples and comparative examples was applied to a PMMA (polymethyl methacrylate resin) substrate (HD6 manufactured by HelioScreen) and dried for 15 minutes to prepare a measurement sample. In addition, an uncoated PMMA substrate was used as a control sample. The transmittance at 1500 nm was measured for each of the measurement sample and the control sample using a spectrophotometer (UV-3600 manufactured by Shimadzu Corporation, integrating sphere mode). During the measurement, the coated surface of the PMMA substrate was attached to the outer edge of the opening of the integrating sphere using double-sided tape. The transmittance of the measurement sample divided by the transmittance of the control sample was determined as the transmittance, and (100% - transmittance) was determined as the infrared cut rate (%).
〈使用感触〉
実施例及び比較例で得られた各化粧料を、専門パネル3名で使用感触について、下記の基準に基づいて、総合評価した:
「A」:みずみずしさに非常に優れる。
「B」:みずみずしさに優れる。
「C」:みずみずしさに劣る。
<Usage sensation>
The cosmetic compositions obtained in the Examples and Comparative Examples were evaluated by a panel of three experts on the feel of use, based on the following criteria:
"A": Very fresh.
"B": Excellent freshness.
"C": Less fresh.
〈乳化粒子径〉
顕微鏡を用いて、乳化粒子の大きさ(マイクロメーターによる測定)及びその分布状況(検鏡視野の粒子の均一度)を肉眼で総合的に判定することによって、実施例及び比較例で得られた各化粧料のそれぞれの乳化粒子径を求めた。なお、表2において、「1~10(20)」という表現は、大部分の乳化粒子の径が約1~10μmの範囲であり、約20μmまでの少数の乳化粒子も存在したことを意味している。他の表現も同様である。
<Emulsion particle size>
Using a microscope, the size of the emulsion particles (measured with a micrometer) and their distribution (uniformity of particles in the field of view of the microscope) were comprehensively judged with the naked eye to determine the emulsion particle size of each of the cosmetics obtained in the Examples and Comparative Examples. Note that in Table 2, the expression "1-10 (20)" means that the majority of the emulsion particles had a diameter in the range of about 1-10 μm, with a small number of emulsion particles up to about 20 μm being present. The same applies to other expressions.
表1から明らかであるように、実施例1~9の化粧料は、赤外線防御効果に優れており、かつ独特のみずみずしい使用感触を有することが分かった。 As is clear from Table 1, the cosmetics of Examples 1 to 9 were found to have excellent infrared protection effects and a unique, refreshing feel when used.
また、実施例1~6の化粧料は、実施例7~9の化粧料に比べて、安定性がより優れているのは、ポリヒドロキシステアリン酸を更に含んでいるからと考えられる。なお、実施例7~9の化粧料は、ポリヒドロキシステアリン酸の代わりに、それぞれセスキイソステアリン酸ソルビタン、イソステアリン酸、及びビスブチルジメチコンポリグリセリル-3のような界面活性剤を更に含んでいる。これらの界面活性剤は、粉末分散剤としての機能を有しているが、特に大粒径の金属酸化物粒子に対する分散性は、ポリヒドロキシステアリン酸に比べてやや劣っているではないかと分析される。 The cosmetics of Examples 1 to 6 are more stable than the cosmetics of Examples 7 to 9, which is believed to be due to the inclusion of polyhydroxystearic acid. The cosmetics of Examples 7 to 9 further contain surfactants such as sorbitan sesquiisostearate, isostearic acid, and bisbutyldimethicone polyglyceryl-3, instead of polyhydroxystearic acid. These surfactants function as powder dispersants, but their dispersibility, especially for large metal oxide particles, is considered to be somewhat inferior to that of polyhydroxystearic acid.
Claims (10)
(a)平均粒子径が500~1500nmであり、かつ表面疎水処理された金属酸化物粒子、
(b)疎水変性アルキルセルロース、
(c)水相増粘剤、及び
(d)油分、
前記金属酸化物粒子が、前記油分中に分散されており、かつ
HLB値が10以上のノニオン界面活性剤の含有量が、1.0質量%未満である、
水中油型乳化化粧料。 Contains the following components (a) to (d):
(a) metal oxide particles having an average particle size of 500 to 1,500 nm and having a hydrophobic surface;
(b) hydrophobically modified alkyl cellulose;
(c) an aqueous phase thickener; and (d) an oil.
the metal oxide particles are dispersed in the oil, and the content of a nonionic surfactant having an HLB value of 10 or more is less than 1.0 mass%.
Oil-in-water emulsion cosmetic.
前記疎水変性アルキルセルロースの含有量が、0.05質量%以上1.0質量%以下であり、
前記水相増粘剤の含有量が、0.05質量%以上3.0質量%以下であり、かつ
前記油分の含有量が、5.0質量%以上40.0質量%以下である、
請求項1又は2に記載の化粧料。 The content of the metal oxide particles is 1.0% by mass or more and 30.0% by mass or less,
The content of the hydrophobically modified alkyl cellulose is 0.05% by mass or more and 1.0% by mass or less,
The content of the aqueous phase thickener is 0.05% by mass or more and 3.0% by mass or less, and the content of the oil content is 5.0% by mass or more and 40.0% by mass or less.
The cosmetic preparation according to claim 1 or 2.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021019991A JP7645654B2 (en) | 2021-02-10 | 2021-02-10 | Oil-in-water emulsion cosmetics |
| CN202280009506.1A CN116940334A (en) | 2021-02-10 | 2022-01-31 | Oil-in-water type emulsified cosmetic |
| PCT/JP2022/003630 WO2022172799A1 (en) | 2021-02-10 | 2022-01-31 | Oil-in-water emulsion cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021019991A JP7645654B2 (en) | 2021-02-10 | 2021-02-10 | Oil-in-water emulsion cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022122633A JP2022122633A (en) | 2022-08-23 |
| JP7645654B2 true JP7645654B2 (en) | 2025-03-14 |
Family
ID=82838820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021019991A Active JP7645654B2 (en) | 2021-02-10 | 2021-02-10 | Oil-in-water emulsion cosmetics |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP7645654B2 (en) |
| CN (1) | CN116940334A (en) |
| WO (1) | WO2022172799A1 (en) |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007246454A (en) | 2006-03-16 | 2007-09-27 | Kose Corp | Oil-in-water sunscreen |
| JP2012519166A (en) | 2009-07-24 | 2012-08-23 | コリアナ コスメティックス カンパニー リミテッド | Composite powder for simultaneous blocking of infrared and ultraviolet rays and cosmetic composition using the same |
| JP2015120682A (en) | 2013-11-19 | 2015-07-02 | 株式会社 資生堂 | Oil-in-water emulsion cosmetic |
| JP2017095361A (en) | 2015-11-18 | 2017-06-01 | 花王株式会社 | Near-infrared protective cosmetic composition |
| WO2018105040A1 (en) | 2016-12-06 | 2018-06-14 | 株式会社 資生堂 | Oil-in-water type emulsion cosmetic |
| WO2018221606A1 (en) | 2017-05-31 | 2018-12-06 | 株式会社 資生堂 | Cosmetic |
| WO2020032246A1 (en) | 2018-08-10 | 2020-02-13 | 株式会社 資生堂 | Sunscreen effect enhancer |
| JP2020063228A (en) | 2018-10-11 | 2020-04-23 | 堺化学工業株式会社 | Oil-in-water emulsified cosmetic and method for producing the same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2010067881A1 (en) * | 2008-12-12 | 2012-05-24 | 協和化学工業株式会社 | Cosmetic composition |
| CN102228412A (en) * | 2011-05-10 | 2011-11-02 | 蒲科 | Oil phase dispersion sunblocking concentrate of nanometer titania and preparation method thereof |
| CN106572958B (en) * | 2014-11-28 | 2020-11-06 | 株式会社资生堂 | Oil-in-water type emulsion cosmetic |
| CN109498497B (en) * | 2018-12-27 | 2022-02-11 | 唯客乐化妆品(杭州)有限公司 | Eyebrow pencil liquid and its production process |
-
2021
- 2021-02-10 JP JP2021019991A patent/JP7645654B2/en active Active
-
2022
- 2022-01-31 CN CN202280009506.1A patent/CN116940334A/en active Pending
- 2022-01-31 WO PCT/JP2022/003630 patent/WO2022172799A1/en not_active Ceased
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007246454A (en) | 2006-03-16 | 2007-09-27 | Kose Corp | Oil-in-water sunscreen |
| JP2012519166A (en) | 2009-07-24 | 2012-08-23 | コリアナ コスメティックス カンパニー リミテッド | Composite powder for simultaneous blocking of infrared and ultraviolet rays and cosmetic composition using the same |
| JP2015120682A (en) | 2013-11-19 | 2015-07-02 | 株式会社 資生堂 | Oil-in-water emulsion cosmetic |
| JP2017095361A (en) | 2015-11-18 | 2017-06-01 | 花王株式会社 | Near-infrared protective cosmetic composition |
| WO2018105040A1 (en) | 2016-12-06 | 2018-06-14 | 株式会社 資生堂 | Oil-in-water type emulsion cosmetic |
| WO2018221606A1 (en) | 2017-05-31 | 2018-12-06 | 株式会社 資生堂 | Cosmetic |
| WO2020032246A1 (en) | 2018-08-10 | 2020-02-13 | 株式会社 資生堂 | Sunscreen effect enhancer |
| JP2020063228A (en) | 2018-10-11 | 2020-04-23 | 堺化学工業株式会社 | Oil-in-water emulsified cosmetic and method for producing the same |
Non-Patent Citations (1)
| Title |
|---|
| Balancing Oshiroi Milk C SPF 50+ PA++++,ID 7661951,Mintel GNPD[online],2020年05月,[検索日2022.03.17] |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022122633A (en) | 2022-08-23 |
| CN116940334A (en) | 2023-10-24 |
| WO2022172799A1 (en) | 2022-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6279457B2 (en) | Oil-in-water emulsified cosmetic | |
| US11077048B2 (en) | Oil-in-water emulsion cosmetic | |
| US11266591B2 (en) | Oil-in-water type emulsion cosmetic | |
| EP2529727B1 (en) | Water-in-oil emulsion sunscreen cosmetic composition | |
| JP6878462B2 (en) | Underwater oil type emulsified cosmetic | |
| JP6757713B2 (en) | Oil-in-water emulsified composition | |
| JPWO2020032246A1 (en) | Sunscreen effect enhancer | |
| EP2609902B1 (en) | Water-in-oil emulsified cosmetic preparation | |
| CN114641274B (en) | Oil-in-water type composition | |
| JP7645654B2 (en) | Oil-in-water emulsion cosmetics | |
| WO2023286780A1 (en) | Oil-in-water emulsion composition | |
| JPWO2020032245A1 (en) | Cosmetics | |
| WO2022168839A1 (en) | Composition | |
| TWI689316B (en) | Oil-in-water emulsion cosmetics | |
| JP2026002640A (en) | Oil-in-water cosmetics | |
| HK1230984A1 (en) | Oil-in-water type emulsion cosmetic | |
| HK1178080B (en) | Water-in-oil emulsion sunscreen cosmetic composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20231208 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20241029 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250218 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20250304 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7645654 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |